Legislation & Regulation

On November 16th, 2017, CMS released a much anticipated proposed rule that amends regulations for Medicare Part C and Medicare Part D to implement provisions of the Comprehensive Addiction and Recovery Act (CARA) and the 21st Century Cures Act. The proposed rule also makes changes to improve program quality, accessibility, and affordability and also adopts the updated NCPDP script standard for electronic prescribing.

Press Release: the Centers for Medicare and Medicaid Services (CMS) released a much anticipated proposed rule titled “Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.”

AMCP CEO Blog: Health care reform historically has one of the most contentious issues on Capitol Hill. The current fight to repeal the Affordable Care Act (ACA) is just the latest in a string of battles that reaches back many decades, including to the founding of Medicare and Medicaid.

AMCP CEO Blog: A recent article in The New England Journal of Medicine (NEJM) caught my attention for a couple of reasons.

AMCP webinar that reviewed the FDA Reauthorization Act of 2017 (FDARA) which authorizes user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilars.

Press Release: The Academy of Managed Care Pharmacy (AMCP) commends the House for its passage yesterday of H.R. 2430, the Food and Drug Administration Reauthorization Act (FDARA) of 2017. H.R. 2430 reauthorizes FDA’s critical user fee programs.

Press Release: The U.S. House Energy and Commerce Committee’s Subcommittee on Health held a hearing today on the “Pharmaceutical Information Exchange (PIE) Act of 2017” (H.R. 2026).